Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases.

MLA

Dong, Wen-sheng, et al. “Metrnl: A Promising Biomarker and Therapeutic Target for Cardiovascular and Metabolic Diseases.” Cell Communication & Signaling, vol. 22, no. 1, Aug. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12964-024-01767-8.

APA

Dong, W., Hu, C., Hu, M., Gao, Y., Hu, Y., Li, K., Ye, Y., & Zhang, X. (2024). Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases. Cell Communication & Signaling, 22(1), 1–12. https://doi.org/10.1186/s12964-024-01767-8

Chicago

Dong, Wen-sheng, Can Hu, Min Hu, Yi-peng Gao, Yu-xin Hu, Kang Li, Yun-jia Ye, and Xin Zhang. 2024. “Metrnl: A Promising Biomarker and Therapeutic Target for Cardiovascular and Metabolic Diseases.” Cell Communication & Signaling 22 (1): 1–12. doi:10.1186/s12964-024-01767-8.